𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Age as a Predictor of Cognitive Decline in Bipolar Disorder

✍ Scribed by Lewandowski, Kathryn E.; Sperry, Sarah H.; Malloy, Mary C.; Forester, Brent P.

Book ID
123318057
Publisher
American Psychiatric Publishing Inc
Year
2014
Tongue
English
Weight
239 KB
Volume
22
Category
Article
ISSN
1064-7481

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Homocysteine as a predictor of cognitive
Homocysteine as a predictor of cognitive decline in Alzheimer's disease
✍ Abderrahim Oulhaj; Helga Refsum; Helen Beaumont; Jonathan Williams; Elizabeth Ki πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 272 KB πŸ‘ 1 views

## Abstract ## Objective Moderately elevated levels of plasma total homocysteine are associated with an increased risk of developing Alzheimer's disease. We have tested whether baseline concentrations of homocysteine relate to the subsequent rate of cognitive decline in patients with established A

Anxiety disorder and accompanying subjec
Anxiety disorder and accompanying subjective memory loss in the elderly as a predictor of future cognitive decline
✍ Gary Sinoff; Perla Werner πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 96 KB πŸ‘ 1 views

## Abstract ## Objective The aim of the study was to empirically investigate the hypothesis that anxiety in the elderly, secondary to loss of memory, predicts future cognitive decline. ## Method The participants were 137 elderly subjects with no depression or cognitive impairment from a communit

Scopolamine-induced cognitive impairment
Scopolamine-induced cognitive impairment as a predictor of cognitive decline in healthy elderly volunteers
✍ Dr. Andrew Barker; Roy Jones; Pauline Simpson; Keith Wesnes πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 312 KB πŸ‘ 1 views

## Abstract There are theoretical grounds for believing that scopolamine‐induced cognitive deficit may be predictive of future cognitive decline. In the present study, 22 healthy elderly volunteers were reassessed 3 years after a scopolamine challenge. Although there was little overall change in me